Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.
about
Pseudovirions as vehicles for the delivery of siRNAPersistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infectionProduction of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vectorExpanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategiesUse of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeVaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.Replication-Competent Controlled Herpes Simplex Virus.Versatility of gene therapy vectors through viruses.HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in miceDevelopment and application of replication-incompetent HSV-1-based vectors.Prospects for developing an effective vaccine against ocular herpes simplex virus infection.HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.Genetic engineering of a modified herpes simplex virus 1 vaccine vector.Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.HSV Recombinant Vectors for Gene Therapy.Pre-existing immunity against vaccine vectors--friend or foe?A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1.Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells.
P2860
Q24634231-416EF5A9-F171-4B69-BD43-F52E46D61C95Q24806094-71BA96B8-98F4-46D9-B7F1-BE5DC7825728Q26247032-1DF6F5F3-8177-4280-820E-E0B00DB635B3Q33440600-33B61A70-44B8-41A2-8705-F6F740F4704EQ33833779-574A870A-AB76-45C5-95B7-05D88B4F19FDQ33916162-8BE3D9D9-9B8E-4F5F-9514-9918C63577CFQ34594102-2E40E1C9-6763-405F-9EB9-189A51F1F6C2Q36017935-6D10FD95-D5ED-4930-BF74-E07B2AFDD561Q36086213-B7F249AE-1F46-499F-A19A-88066E5865F6Q36150489-C9A633B9-BC0A-4FC4-982C-9C0B4D88C347Q36156347-2BB668A0-52DF-439E-B42D-FB3792264470Q36288938-981F6AF4-4673-461D-AEB5-19EEA7CBEFA9Q36311038-4CC5D115-E19E-43D0-B6D7-B6E632AE22C4Q36897379-39F684E7-CAFD-4806-BF75-6763AD965652Q37188682-053B6F03-E028-4925-8171-53A40FF207B9Q37456642-81A0758A-289D-47C1-829A-704BB2A3524EQ37528088-6CED6EFA-4F6B-4D50-99E3-4EDD9168BA57Q37596491-3E720D1A-CC21-4733-A8B7-431D3AA998A6Q37787777-E6F91D90-ABB9-4071-8CC4-5DCDA64B0537Q38061876-C28825F3-E02A-413F-ACE0-22BD16CFF95EQ38353693-45876658-6D12-4D09-95EA-3D1EA0C15CD8Q40521843-D2C68E96-2C12-46EA-9D67-C29E105E07EBQ41495016-E8C2A5C6-18D3-4FFA-AF1B-85303454B1EE
P2860
Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Herpes simplex virus vectors e ...... of preexisting host immunity.
@ast
Herpes simplex virus vectors e ...... of preexisting host immunity.
@en
Herpes simplex virus vectors e ...... of preexisting host immunity.
@nl
type
label
Herpes simplex virus vectors e ...... of preexisting host immunity.
@ast
Herpes simplex virus vectors e ...... of preexisting host immunity.
@en
Herpes simplex virus vectors e ...... of preexisting host immunity.
@nl
prefLabel
Herpes simplex virus vectors e ...... of preexisting host immunity.
@ast
Herpes simplex virus vectors e ...... of preexisting host immunity.
@en
Herpes simplex virus vectors e ...... of preexisting host immunity.
@nl
P2860
P1433
P1476
Herpes simplex virus vectors e ...... of preexisting host immunity.
@en
P2093
David M Knipe
P2860
P304
P356
10.1128/JVI.76.8.3678-3687.2002
P407
P577
2002-04-01T00:00:00Z